Table 1.
Advantage | Drawback | |
---|---|---|
Design | Allowing the introduction of several immunological components; synthetic and PCR methods for simple modifications | Low transfection efficiency |
Manufacture | Rapid production and formulation; easily engineered, reproducible, large-scale production and isolation | |
Safety | No pathogenic infection in vivo; no significant adverse events in any clinical trial; neutralizing immune responses rarely observed; boost strategy is possible | |
Stability | Long shelf life; relative temperature insensitivity; lack necessity of a cold chain stored on a large scale | |
Immunogenicity | Lower immunogeni-city in larger animals and human compared to mice |